MK-6482, a hypoxia-inducible factor 2a inhibitor (HIF-2a), versus everolimus in heavily pretreated, immune checkpoint-inhibitor-resistant, advanced clear cell renal cell carcinoma (ccRCC): Phase III study.
MK-6482;Everolimus
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: MK-6482, a hypoxia-inducible factor 2a inhibitor (HIF-2a), versus everolimus in heavily pretreated, immune checkpoint-inhibitor-resistant, advanced clear cell renal cell carcinoma (ccRCC): Phase III study. ### Output: MK-6482;Everolimus